Assessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated With Adenovirus Vaccine Against COVID-19.
Clinical trial NCT05305573 · COMPLETED
Trial details
- NCT number
- NCT05305573
- Sponsor
- Hipra Scientific, S.L.U
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-25
- Primary completion
- 2022-10-01
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.